FDA Inspection 1177168 — Resoundant Inc.
The FDA completed an inspection of Resoundant Inc. on Jul 20, 2022 in Rochester, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 20, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Rochester, MN (United States)